Can the therapeutic advantages of allogenic umbilical cord blood-derived stem cells and autologous bone marrow-derived mesenchymal stem cells be combined and synergized?
10.1097/01.mat.0000235330.02549.78
Saved in:
Main Authors: | Heng, B.C., Phan, T.T., Liu, H., Ouyang, H.W., Cao, T. |
---|---|
Other Authors: | SURGERY |
Format: | Editorial |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/24219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Can the therapeutic advantages of allogenic umbilical cord blood-derived stem cells and autologous bone marrow-derived mesenchymal stem cells be combined and synergized?
by: Heng, B.C., et al.
Published: (2013) -
Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: An observational cohort study
by: Nejadnik, H., et al.
Published: (2014) -
Reduction of Emphysema Severity by Human Umbilical Cord-Derived Mesenchymal Stem Cells in Mice
by: Laiman, Vincent, et al.
Published: (2022) -
Lipopolysaccharide’s Cytotoxicity on Human Umbilical Cord
Mesenchymal Stem Cells
by: Mefina Kuntjoro, -, et al.
Published: (2020) -
Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: A case report
by: Areesak Chotivichit, et al.
Published: (2018)